Archive

The SAIVE trial for prevention of COVID-19

Written by Christine Clark | 8 Feb 2023

Professor Colleen Aldous is a research professor at in the School of Clinical Medicine at the University of Kwazulu-Natal in South Africa. She recently described the SAIVE trial… read more.

How the totality of evidence for ivermectin informs clinical practice

Written by Christine Clark | 7 Feb 2023

Colleen Aldous, Professor for Medical Research, University of KwaZulu-Natal explains how the evidence supporting the use of ivermectin for covid-19 came together to tell a compelling story. In… read more.

Addressing the totality of evidence for ivermectin

Written by Christine Clark | 6 Feb 2023

When assessing repurposed drugs in a pandemic situation, the totality of evidence should be considered rather than RCTs alone; had this been done the pandemic could have been… read more.

TOGETHER trial shows positive effect for ivermectin

Written by Christine Clark | 5 Feb 2023

The TOGETHER trial was widely reported as showing that ivermectin was not effective in covid-19, but a straightforward analysis of the results reveals a 59 per cent reduction… read more.

Ivermectin – is it safe and effective?

Written by Christine Clark | 4 Feb 2023

The best time to administer ivermectin is at the beginning of a covid-19 infection so that virus is killed and disease progression averted, according to Colleen Aldous, Professor… read more.

What makes the SAIVE study so good?

Written by Christine Clark | 3 Feb 2023

Professor Colleen Aldous is a research professor at the School of Clinical Medicine at the University of Kwazulu-Natal in South Africa. She recently described the SAIVE trial of… read more.